Neuro-oncologists report disruptions to treatment and increased stress due to COVID-19

An international survey of neuro-oncologists has identified widespread disruptions in the delivery of patient care and clinical research due to COVID-19.

Dr Milan Chheda of the Washington University School of Medicine in St Louis, Missouri, USA, and colleagues conducted an international, web-based survey to assess the impact of the pandemic.